Last reviewed · How we verify

NCT06271525: CT

Effect of Cupping Therapy on Nitric Oxide Level in Patients With Cervical Spondylosis

Status unknown NA Last updated 21 February 2024
What this trial tests

NA trial testing cupping therapy in Cervical Spondylosis in 60 participants. Status unknown.

Timeline
20 February 2024
Primary endpoint
20 May 2024
20 May 2024

Quick facts

Lead sponsorShady Abdelsattar Refaat
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment60
Start date20 February 2024
Primary completion20 May 2024
Estimated completion20 May 2024

Drugs / interventions tested

Conditions studied

Sponsor

Shady Abdelsattar Refaat

Who can join

Adults 24 to 65, any sex, with Cervical Spondylosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

this study will be conducted to investigate the effect of cupping therapy on the nitric oxide level in patients with cervical spondylosis

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of cupping therapy

Trials testing the same drug.

Other recruiting trials for Cervical Spondylosis

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06271525.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing